|
Market Cap (25-Jun) $27,342,400 (1,032nd) |
Close (30-Jun) $0.008 |
Volume (30-Jun) 285,280 |
Shortsold (12-Dec) 6,497 (0.00%) (681st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.09 |
EX1 released this announcement to the ASX on 2 December 2020, 18:54. The announcement is not marked as price sensitive, and is 15 page(s) in length and 292.13kb in size.
You can view all announcements from EX1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, EX1 was 0.011% short sold according to ASIC data. It was ranked the 588th most shorted stock on the ASX. It remains ranked 681st as of the latest reported data (12 December 2022).
| Other Recent Announcements from EX1 | |
|---|---|
| Initial Director's Interest Notice - MD | 22 June 2023, 11:52 |
| Change of Director's Interest Notice - CB | 22 June 2023, 11:51 |
| Final Director's Interest Notice - JW | 22 June 2023, 11:50 |
| Appendix 2A | 2 December 2020, 18:54 |
| Results of Meeting | 30 November 2020, 13:04 |
| Change of Registered Office Address | 13 November 2020, 17:15 |
| Updated Quarterly Activities Report | 13 November 2020, 15:13 |
You must be logged in to post a reply.
Exopharm 